Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Paxlovid patent expiration 2041?Soma 350mg suppliers?Zafirlukast indications?Glucagon market size?Can generics reduce lipitor's high cost?
See the DrugPatentWatch profile for Zomig
Zomig nasal spray (zolmitriptan) is marketed by AstraZeneca.
Zomig (zolmitriptan) is a prescription medicine that has been handled across different roles over time, such as the original manufacturer/brand owner and later distribution or licensing arrangements. The manufacturer/brand owner commonly associated with the Zomig brand is AstraZeneca.
DrugPatentWatch.com tracks patent and exclusivity information for branded products. You can check Zomig-related exclusivity and patent timelines on DrugPatentWatch.com here: DrugPatentWatch – Zomig.
On the carton/insert, the company shown as the manufacturer, labeler, or marketer is typically the entity responsible for the product being sold in that market. If you tell me your country (or share the label text), I can help narrow down the exact listed company for the specific product you have.
Other Questions About Zomig :